Investors archive
Novozymes stock exchange
announcements & investor news

Here you can explore previous stock exchange announcements & investor news for Novozymes.

For the newest company announcements, please visit the Novonesis company announcements page

Novozymes stock exchange announcements & investor news

NoMonthDateTitleDownload
INJanuary24Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt mergerDownload announcement
1January25Proposal of candidates to the Board of DirectorsDownload announcement
2January26Group financial statement for 2022Download announcement
2January26Annual report 2022Download report
2January26Annual report iXBRLDownload report
3January27Trading by management and close relations of management (Release of incentive program for EBG, LAG, TSJA, ALUN, CCF, GDS)Download announcement
4January27Trading by management and close relations of management (JRAS)Download announcement
5January27Trading by management and close relations of management (EBG)Download announcement
6January27Trading by management and close relations of management (MOAS)Download announcement
7January27Trading by management and close relations of management (CJON)Download announcement
8January30Trading by management and close relations of management (ANBU)Download announcement
9February1Trading by management and close relations of management (Novo Holdings)Download announcement
10February1Trading by management and close relations of management (GDS)Download announcement
11February2Trading by management and close relations of management (Novo Holdings)Download announcement
12February2Trading by management and close relations of management (ANBU)Download announcement
13February2Trading by management and close relations of management (CJON)Download announcement
 February3Invitation to Novozymes' annual shareholders' meeting 2023Download announcement
14February3Trading by management and close relations of management (Novo Holdings)Download announcement
15February6Trading by management and close relations of management (Novo Holdings)Download announcement
16February7Trading by management and close relations of management (Novo Holdings)Download announcement
17February8Trading by management and close relations of management (Novo Holdings)Download announcement
18February9Trading by management and close relations of management (Novo Holdings)Download announcement
19February10Trading by management and close relations of management (Novo Holdings)Download announcement
20February10Trading by management and close relations of management (ALBY)Download announcement
21February13Trading by management and close relations of management (Novo Holdings)Download announcement
22February14Trading by management and close relations of management (Novo Holdings)Download announcement
23February15Trading by management and close relations of management (Novo Holdings)Download announcement
24February16Trading by management and close relations of management (Novo Holdings)Download announcement
25February17Trading by management and close relations of management (Novo Holdings)Download announcement
26February18Trading by management and close relations of management (Novo Holdings)Download announcement
27February21Trading by management and close relations of management (Novo Holdings)Download announcement
28February22Trading by management and close relations of management (Novo Holdings)Download announcement
29February23Trading by management and close relations of management (Novo Holdings)Download announcement
30February27Trading by management and close relations of management (Novo Holdings)Download announcement
31February27Trading by management and close relations of management (Novo Holdings)Download announcement
32February28Trading by management and close relations of management (Novo Holdings)Download announcement
33March1Trading by management and close relations of management (Novo Holdings)Download announcement
34March2Trading by management and close relations of management (Novo Holdings)Download announcement
35March2Resolutions from Novozymes A/S’ Annual Shareholders’ Meeting 2023Download announcement
36March3Trading by management and close relations of management (Novo Holdings)Download announcement
37March6Trading by management and close relations of management (Novo Holdings)Download announcement
38March7Trading by management and close relations of management (Novo Holdings)Download announcement
39March8Publication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combined companyDownload announcement
 March8Invitation to an extraordinary shareholders' meeting of Novozymes A/SDownload announcement
40March8Trading by management and close relations of management (Novo Holdings)Download announcement
41March10Trading by management and close relations of management (Novo Holdings)Download announcement
42March10Trading by management and close relations of management (Novo Holdings)Download announcement
43March13Trading by management and close relations of management (Novo Holdings)Download announcement
44March14Trading by management and close relations of management (Novo Holdings)Download announcement
45March15Trading by management and close relations of management (Novo Holdings)Download announcement
46March16Trading by management and close relations of management (Novo Holdings)Download announcement
47March17Trading by management and close relations of management (Novo Holdings)Download announcement
48March20Trading by management and close relations of management (Novo Holdings)Download announcement
49March23Trading by management and close relations of management (Novo Holdings)Download announcement
INMarch28Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completionDownload announcement
50March30Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholdersDownload announcement
51March30Resolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023Download announcement
INMarch30Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partnerDownload announcement
52April26Interim report for Q1 2023Download announcement
53May4Change to the Executive Leadership TeamDownload announcement
54August9Interim report for 1H 2023Download announcement
55August15Trading by management and close relations of management (GDS)Download announcement
56August25Trading by management and close relations of management (CCF)Download announcement
INSeptember4Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completionDownload announcement
57October10Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. HansenDownload announcement
INOctober10Interim dividend paymentDownload announcement
58October26Interim report for 9M 2023Download announcement
59October30Trading by management and close relations of management (Kasim Kutay)Download announcement
INNovember20Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European CommissionDownload announcement
60November24Trading by management and close relations of management (ANBU)Download announcement
INDecember12Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained.Download announcement
61December13Novozymes’ updated financial calendarDownload announcement
NoMonthDateTitleDownload
1February1Group financial statement for 2021Download announcement
1February1Annual report 2021Download report
 February11Invitation to Novozymes’ annual shareholders’ meeting 2022Download announcement
2February21Initiation of stock buyback programDownload announcement
3February28Transactions under Novozymes’ stock buyback programDownload announcement
4March7Transactions under Novozymes’ stock buyback programDownload announcement
5March14Transactions under Novozymes’ stock buyback programDownload announcement
6March16Novozymes A/S’ Annual Shareholders’ Meeting 2022Download announcement
7March21Transactions under Novozymes’ stock buyback programDownload announcement
8March28Transactions under Novozymes’ stock buyback programDownload announcement
9April4Transactions under Novozymes’ stock buyback programDownload announcement
10April11Transactions under Novozymes’ stock buyback programDownload announcement
11April19Transactions under Novozymes’ stock buyback programDownload announcement
12April20Reduction of share capitalDownload announcement
13April25Transactions under Novozymes’ stock buyback programDownload announcement
14April26Interim report for Q1 2022Download announcement
15May2Transactions under Novozymes’ stock buyback programDownload announcement
16May9Transactions under Novozymes’ stock buyback programDownload announcement
17May16Transactions under Novozymes’ stock buyback programDownload announcement
18May23Transactions under Novozymes’ stock buyback programDownload announcement
19May30Transactions under Novozymes’ stock buyback programDownload announcement
20June7Transactions under Novozymes’ stock buyback programDownload announcement
21June13Transactions under Novozymes’ stock buyback programDownload announcement
22June20Transactions under Novozymes’ stock buyback programDownload announcement
23June27Transactions under Novozymes’ stock buyback program (conclusion)Download announcement
24June29Novozymes’ financial calendar 2023Download announcement
25August11Interim report for 1H 2022Download announcement
26October7Company announcementDownload announcement
27November3Interim report for 9M 2022Download announcement
28December12Novozymes and Chr. Hansen to combineDownload announcement
NoMonthDateTitleDownload
INJanuary8Novozymes completes acquisition of Microbiome LabsDownload announcement
1February2Group financial statement for 2020Download announcement
1February2Annual report 2020Download report
2February2Election of employee representatives to the Board of Directors of Novozymes A/SDownload announcement
3February5Trading by management and close relations of management (Kasim Kutay)Download announcement
4February5Trading by management and close relations of management (Kasim Kutay) - AmendmentDownload announcement
5February8Initiation of stock buyback programDownload announcement
 February11Invitation to Novozymes’ annual shareholders’ meeting 2021Download announcement
6February12Trading by management and close relations of management (TVI)Download announcement
7February15Transactions under Novozymes’ stock buyback programDownload announcement
8February17Trading by management and close relations of management (CCF)Download announcement
9February22Transactions under Novozymes’ stock buyback programDownload announcement
10March1Transactions under Novozymes’ stock buyback programDownload announcement
11March8Transactions under Novozymes’ stock buyback programDownload announcement
12March11Novozymes A/S’ Annual Shareholders’ Meeting 2021Download announcement
13March15Transactions under Novozymes’ stock buyback programDownload announcement
14March22Transactions under Novozymes’ stock buyback programDownload announcement
15March29Transactions under Novozymes’ stock buyback programDownload announcement
16April6Transactions under Novozymes’ stock buyback programDownload announcement
17April12Transactions under Novozymes’ stock buyback programDownload announcement
18April12Reduction of share capitalDownload announcement
19April19Transactions under Novozymes’ stock buyback programDownload announcement
20April26Transactions under Novozymes’ stock buyback programDownload announcement
21April27Interim report for Q1 2021Download announcement
22April29Trading by management and close relations of management (ALUN, TSJA)Download announcement
23May3Transactions under Novozymes’ stock buyback programDownload announcement
24May3Trading by management and close relations of management (Novo Holdings)Download announcement
25May6Trading by management and close relations of management (CCF)Download announcement
26May10Transactions under Novozymes’ stock buyback programDownload announcement
27May17Transactions under Novozymes’ stock buyback programDownload announcement
28May25Transactions under Novozymes’ stock buyback programDownload announcement
29May31Transactions under Novozymes’ stock buyback programDownload announcement
30June7Transactions under Novozymes’ stock buyback programDownload announcement
31June14Transactions under Novozymes’ stock buyback programDownload announcement
32June21Transactions under Novozymes’ stock buyback programDownload announcement
33June28Transactions under Novozymes’ stock buyback programDownload announcement
34July5Transactions under Novozymes’ stock buyback programDownload announcement
35July12Transactions under Novozymes’ stock buyback programDownload announcement
36July19Transactions under Novozymes’ stock buyback programDownload announcement
37July26Transactions under Novozymes’ stock buyback programDownload announcement
38August2Transactions under Novozymes’ stock buyback programDownload announcement
39August9Transactions under Novozymes’ stock buyback programDownload announcement
40August12Novozymes reaches a strategic milestone in the implementation of its strategy with a significant entry into Advanced Protein SolutionsDownload announcement
41August12Interim report for 1H 2021Download announcement
42August16Novozymes’ financial calendar 2022Download announcement
43August16Transactions under Novozymes’ stock buyback programDownload announcement
44August23Transactions under Novozymes’ stock buyback programDownload announcement
45August30Transactions under Novozymes’ stock buyback program (conclusion)Download announcement
46September27Novozymes announces its 2025 strategy: Unlocking growth – powered by biotechDownload announcement
47October26Interim report for 9M 2021Download announcement
48October29Trading by management and close relations of management (Kasim Kutay)Download announcement
49October29Trading by management and close relations of management (GDS)Download announcement
50November11Trading by management and close relations of management (CCF)Download announcement
51November30Novozymes strengthens and expands position in human health and functional foods by acquiring a majority stake in Synergia Life SciencesDownload announcement
52December10Novozymes announces closing of transaction of majority stake in Synergia Life SciencesDownload announcement
53December14Proposal of candidates to the Board of DirectorsDownload announcement
NoMonthDateTitle 
1January23Group financial statement for 2019Download announcement
1January23Annual report 2019Download report
2January23Updated financial calendar for 2020Download announcement
3January23Trading by management and close relations of managementDownload announcement
4January27Trading by management and close relations of managementDownload announcement
5January27Trading by management and close relations of managementDownload announcement
6January28Trading by management and close relations of managementDownload announcement
7January30Trading by management and close relations of managementDownload announcement
 January31Invitation to Novozymes' annual shareholders' meeting 2020Download announcement
8February4Trading by management and close relations of managementDownload announcement
9February6Trading by management and close relations of managementDownload announcement
10February10Initiation of stock buyback programDownload announcement
11February12Trading by management and close relations of managementDownload announcement
12February17Transactions under Novozymes’ stock buyback program (1)Download announcement
13February24Transactions under Novozymes’ stock buyback program (2)Download announcement
14February26Novozymes A/S’ annual shareholders’ meeting 2020Download announcement
15February26Novozymes new remuneration policy for the Executive Management, the Senior Leadership, and all employeesDownload announcement
16March2Transactions under Novozymes’ stock buyback program (3)Download announcement
17March9Transactions under Novozymes’ stock buyback program (4)Download announcement
18March16Transactions under Novozymes’ stock buyback program (5)Download announcement
19March23Transactions under Novozymes’ stock buyback program (6)Download announcement
20March27Reduction of share capitalDownload announcement
21March30Transactions under Novozymes’ stock buyback program (7)Download announcement
22April6Transactions under Novozymes’ stock buyback program (8)Download announcement
23April7Company announcementDownload announcement
24April14Transactions under Novozymes’ stock buyback program (9)Download announcement
25April20Transactions under Novozymes’ stock buyback program (10)Download announcement
26April27Transactions under Novozymes’ stock buyback program (10)Download announcement
27April29Interim report for Q1 2020Download announcement
28May1Trading by management and close relations of management (HDAL)Download announcement
29May4Transactions under Novozymes’ stock buyback program (11)Download announcement
30May4Trading by management and close relations of management (Novo Holding)Download announcement
31May11Transactions under Novozymes’ stock buyback program (12)Download announcement
32May18Transactions under Novozymes’ stock buyback program (13)Download announcement
33May25Trading by management and close relations of management (TVI)Download announcement
34May25Transactions under Novozymes’ stock buyback program (14)Download announcement
35May27Trading by management and close relations of management (ANFO)Download announcement
36June2Transactions under Novozymes’ stock buyback program (15)Download announcement
37June8Novozymes’ financial calendar 2021Download announcement
38June8Transactions under Novozymes’ stock buyback program (16)Download announcement
39June15Transactions under Novozymes’ stock buyback program (17)Download announcement
40June22Transactions under Novozymes’ stock buyback program (18)Download announcement
41June29Transactions under Novozymes’ stock buyback program (19)Download announcement
42July6Transactions under Novozymes’ stock buyback program (20)Download announcement
43July8Trading updateDownload announcement
44July13Transactions under Novozymes’ stock buyback program (21)Download announcement
45July20Transactions under Novozymes’ stock buyback program (22)Download announcement
46July27Transactions under Novozymes’ stock buyback program (23)Download announcement
47August3Transactions under Novozymes’ stock buyback program (24)Download announcement
48August10Transactions under Novozymes’ stock buyback program (25)Download announcement
49August11Interim report for 1H 2020Download announcement
50August17Transactions under Novozymes’ stock buyback program (26)Download announcement
51August17Trading by management and close relations of management (Novo Holding)Download announcement
52August24Transactions under Novozymes’ stock buyback program (27)Download announcement
53September1Changes to managementDownload announcement
54September2Trading by management and close relations of management (EBG)Download announcement
55September4Trading by management and close relations of management (CJON)Download announcement
56September7Trading by management and close relations of management (CJON)Download announcement
57September8Trading by management and close relations of management (CCF)Download announcement
58October21Interim report for 9M 2020Download announcement
59October22Trading by management and close relations of management (CCF)Download announcement
60October28Trading by management and close relations of management (JRAS)Download announcement
61November23Change of management (Amy)Download announcement
62November26Change of management (Morten)Download announcement
63December9Proposal of candidates to the Board of DirectorsDownload announcement
64December11New sales reporting structure introduced. 2020 organic sales growth outlook now expected at 0%, from previously -2% to +2%Download announcement
65December18Novozymes acquires Microbiome LabsDownload announcement
NoMonthDateTitle 
1January24Group financial statement for 2018 Download announcement
1January24Annual report 2018Download report
2January31Change to the Board of DirectorsDownload announcement
 January31Invitation to Novozymes' annual shareholders' meeting 2019Download announcement
3February27Novozymes A/S’ annual shareholders’ meeting 2019Download announcement
4March29Reduction of common stockDownload announcement
5March29Summary of capital reductionDownload announcement
6April4Novozymes and BioAg: Continuation with Bayer as core partner; new, broader setup allows Novozymes to bring biological solutions to the market together with more partnersDownload announcement
7April24Interim report for the first three months of 2019Download announcement
8April29Transactions under Novozymes’ stock buyback programDownload announcement
9April29Agreement between Novozymes and Novo Holdings A/S on trading of shares as part of Novozymes share buyback programDownload announcement
10April29Trading by management and close relations of managementDownload announcement
11May6Transactions under Novozymes’ stock buyback program (1)Download announcement
12May13Transactions under Novozymes’ stock buyback program (2)Download announcement
13May20Transactions under Novozymes’ stock buyback program (3)Download announcement
14May27Transactions under Novozymes’ stock buyback program (4)Download announcement
15June3Transactions under Novozymes’ stock buyback program (5)Download announcement
16June6Company announcementDownload announcement
17June11Transactions under Novozymes’ stock buyback program (6)Download announcement
18June16Strategy update 2020-2022Download announcement
19June17Transactions under Novozymes’ stock buyback program (7)Download announcement
20June24Transactions under Novozymes’ stock buyback program (8)Download announcement
21July1Transactions under Novozymes’ stock buyback program (9)Download announcement
22July8Transactions under Novozymes’ stock buyback program (10)Download announcement
23July15Transactions under Novozymes’ stock buyback program (11)Download announcement
24July22Transactions under Novozymes’ stock buyback program (12)Download announcement
25July29Transactions under Novozymes’ stock buyback program (13)Download announcement
26August5Transactions under Novozymes’ stock buyback program (14)Download announcement
27August8Interim report for the first half of 2019Download announcement
28August8Change to the Executive Leadership Team (PHK)Download announcement
29August9Change to the Board of Directors and Executive Leadership Team – appointment of Executive Vice President and CFODownload announcement
30August12Transactions under Novozymes’ stock buyback program (15)Download announcement
31August19Transactions under Novozymes’ stock buyback program (16)Download announcement
32August26Transactions under Novozymes’ stock buyback program (17)Download announcement
33September2Transactions under Novozymes’ stock buyback program (18)Download announcement
34September9Transactions under Novozymes’ stock buyback program (19)Download announcement
35September16Correction: Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets ActDownload announcement
36September16Transactions under Novozymes’ stock buyback program (20)Download announcement
37September23Transactions under Novozymes’ stock buyback program (21)Download announcement
38September30Transactions under Novozymes’ stock buyback program (22)Download announcement
39October7Transactions under Novozymes’ stock buyback program (23)Download announcement
40October9Company announcementDownload announcement
41October14Transactions under Novozymes’ stock buyback program (24)Download announcement
42October15Change to the Executive Leadership Team (PHN)Download announcement
43October21Transactions under Novozymes’ stock buyback program (25)Download announcement
44October23Interim report for the first nine months of 2019Download announcement
45October25Financial calendar 2020Download announcement
46October28Transactions under Novozymes’ stock buyback program (26)Download announcement
47October30Ester Baiget appointed new CEO of NovozymesDownload announcement
48November4Transactions under Novozymes’ stock buyback program (27)Download announcement
49November 5Trading by management and of close relations to managementDownload announcement
50November11Transactions under Novozymes’ stock buyback program (28)Download announcement
51November18Transactions under Novozymes’ stock buyback program (29)Download announcement
52December11Candidates proposed for the Board of DirectorsDownload announcement
  • Company announcements

    Stay informed and keep up to date on company announcements. Don't forget to sign up for our notification alerts to receive these updates directly.

  • Stock information

    Explore Novonesis' stock performance, ownership structure, the analysts covering Novonesis and the latest consensus.

  • Corporate governance

    We believe that proactive and transparent corporate governance promotes sustainable business behavior and long-term value creation

  • Contact investor relations

    Should you have any questions about results and events, please don't hesitate to get in touch with our investor relations team.

  • Investor homepage

    Are you interested in further exploring investor-related information? Check out our Investor homepage.